VITL Vital Farms Inc

BENSALEM, Pa., Oct. 14 /PRNewswire-FirstCall/ -- Stelex, a firm providing enterprise-wide compliance solutions to the regulated industries, today announced that its Enterprise Asset Management (EAM) group has been awarded a long term contract to provide Maximo Implementation and Quality Assurance services to a client in the Transportation industry. As part of the new Master Services Agreement, Stelex will provide various resources to the project including system administrators, developers, project managers, functional engineers, and quality assurance personnel to upgrade the client from Maximo 6.2 to Maximo 7.1. "We have implemented EAM solutions for some of the largest Life Science companies and we are excited to expand our service and solution offerings to industry verticals outside of the Life Sciences," said Tony Kashani, President of Stelex. The Stelex EAM Services Group consists of IBM Certified Deployment Professionals for Maximo 6 EAM, as well as skilled end-users of Maximo that bring real-life experiences and technical know-how to each and every project. About Stelex Stelex is a consulting firm providing enterprise-wide compliance solutions to regulated industries in the Pharmaceutical, Medical Device, Diagnostic and Biotechnology sectors for over 20 years. The firm delivers a comprehensive suite of Technology, Regulatory and Business solutions. Learn more about Stelex at http://www.stelex.com/. Stelex is a subsidiary of Vital Signs, Inc. (NASDAQ:VITL). Vital Signs provides products and services to the hospital market and FDA regulated industries. Vital Signs is ISO 9001 certified and has CE Mark approval for its products. All statements in this press release other than historical statements constitute Forward Looking Statements under the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements as a result of a variety of factors, including but not limited to the changes in regulatory requirements in the United States and elsewhere, timing and effectiveness of changes to marketing and sales plans, programs and strategies; market conditions; customer response; technological change; and competition and other factors referred to by Vital Signs in its Annual Report on Form 10-K for the year ended September 30, 2007 and other reports filed with the Securities and Exchange Commission. CONTACT: Stelex Sandra Rodriguez Phone: 215-638-9700 http://www.stelex.com/ DATASOURCE: Stelex CONTACT: Sandra Rodriguez of Stelex, +1-215-638-9700, Web site: http://www.stelex.com/

Copyright